Curr cancer drug targets impact factor
WebHeat shock factor 1 (HSF1) was discovered in 1984 as the master regulator of the heat shock response. ... Curr Cancer Drug Targets. 2024;19(7):515-524. doi: 10.2174/1568009618666181018162117. Authors ... In order for these discoveries to reach clinical impact, further development of HSF1 as a biomarker or therapeutic target needs … WebIt is a companion to the highly regarded review journal Current Opinion in Pharmacology (2024 Journal Impact Factor 5.547, CiteScore 9.3) and is part of the Current Opinion and Research (CO+RE) suite of journals. All CO+RE journals leverage the Current Opinion legacy-of editorial excellence, high-impact, and global reach-to ensure they are a ...
Curr cancer drug targets impact factor
Did you know?
WebCurrent Cancer Drug Targets is an impact factor journal that covers the full spectrum of cancer drug discovery and development for researchers and oncologists. newsletter banner. ... Researchers can access related articles from current and back volumes by purchasing access to these collections. Subscribers will also have access to new articles ... WebBentham Science Publishers. Bentham Science is a science, technology, and medical publisher, providing academic researchers and industrial professionals with the latest information in diverse fields of science and technology. Our peer-reviewed scholarly journals and books have an ever-increasing readership of millions of researchers worldwide.
WebHeat shock factor 1 (HSF1) was discovered in 1984 as the master regulator of the heat shock response. ... Curr Cancer Drug Targets. 2024;19(7):515-524. doi: … WebCurrent Problems in Cancer. Journal Abbreviation: CURR PROB CANCER. Journal ISSN: 0147-0272. Year. Impact Factor (IF) Total Articles. Total Cites. 2024 (2024 update) 2.367.
WebAims and scope. Current Cancer Drug Targets aims to cover all the latest and outstanding developments on the medicinal chemistry, pharmacology, molecular biology, genomics and biochemistry of contemporary molecular drug targets involved in cancer, e.g. disease specific proteins, receptors, enzymes, genes. Current Cancer Drug Targets publishes ... http://www.eurekaselect.com/
WebApr 7, 2024 · Journal of Drug Targeting publishes papers and reviews on all aspects of drug delivery and targeting for molecular and macromolecular drugs including the design and characterization of carrier systems (whether colloidal, protein or polymeric) for both vitro and/or in vivo applications of these drugs. Papers are not restricted to drugs delivered ...
WebCurrent Cancer Drug Targets publishes original research papers in the field of Biological Sciences, Oncology and Cancer Research and Pharmacology. The journal is directed at professors, practitioners and researchers who keen on such topics of academic research. The primary research topics published in this academic venue include Cancer research ... port of prince rupert jobsWebCurrent Cancer Drug Targets publishes original research papers in the field of Biological Sciences, Oncology and Cancer Research and Pharmacology. The journal is directed at … port of prince timeWebAbout Current Drug Targets. Current Drug Targets aims to cover the latest and most outstanding developments on the medicinal chemistry and pharmacology of molecular … iron icd-10WebCurrent Cancer Drug Targets is a journal indexed in SJR in Drug Discovery and Pharmacology with an H index of 96. It has an SJR impact factor of 0.732 and it has a best quartile of Q2. It is published in English. It has an SJR … iron icd 10WebCurrent Cancer Drug Targets is an impact factor journal that covers the full spectrum of cancer drug discovery and development for researchers and oncologists. newsletter … iron i beam pricesWebCurrent Problems in Cancer seeks to promote and disseminate innovative, transformative, and impactful data on patient-oriented cancer research and clinical care. Specifically, the journal's scope is focused on reporting the results of well-designed cancer studies that influence/alter practice or …. The average number of weeks it takes for an ... iron i beamWebCurrent Cancer Drug Targets. ISSN (Print): 1568-0096 ISSN (Online): 1873-5576. Volume 23 , Issues 11, 2024. This journal supports open access. Back Journal Home Submit Abstracts Submit Manuscripts. Impact Factor. Current: 2.907 5 - Year: 3.516. Ranking & Category. ONCOLOGY 140th of 222; Topic(s) Covered. port of protection alaska cast